Work

Pretreatment Tumor-infiltrating CD8 + T Cell Numbers Are Associated With the Response to Tremelimumab Plus Durvalumab in Hepatocellular Carcinoma

FWCI: 2.778
Cites:
Cited by: 1
Related to: